By AuntMinnieEurope.com staff writers

August 9, 2017 -- Royal Philips, the parent company of Philips Healthcare, has completed its tender offer for vascular intervention equipment manufacturer Spectranetics.

As a result, Philips expects it will finalize its $2.2 billion (1.87 billion euro) acquisition of Spectranetics on 9 August. Spectranetics shareholders will receive $38.50 (32.79 euros) per share in cash.

Spectranetics will now become a wholly owned subsidiary of Philips.


Copyright © 2017 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: